Tillotts was founded in the UK in 1963, originally as a distributor for herbal gastric ulcer treatments.
Following the launch of Colpermin® capsules and Asacol® tablets in 1981 and 1986 respectively, Tillotts Pharma AG relocated to Switzerland and, in 1999 was the subject of a management buy-out.
In parallel to developing a successful gastro-intestinal (GI) franchise, Tillotts Services was established to provide development and manufacturing expertise specifically in liquid-fill encapsulation using two-piece, hard-shell capsules. In September 2009, Tillotts Pharma AG was acquired by Zeria Pharmaceuticals Co. Ltd., and is now part of a global and fully-integrated healthcare company.
Tillotts Services was re-launched in October 2010 at CPhI in Paris with the addition of an enhanced Contract research services division to its already successful Contract manufacturing business.
With over 26 years experience in commercial liquid-fill manufacturing, Tillotts Services are a safe and reliable supplier for all your developmental and commercial liquid-fill needs.
Our capabilities have been established, and continuously tested through solving the most difficult and demanding problems in formulation design and development. Our history in targeting drug delivery to the lower intestines has been demonstrated in the successful development of several global products that includes Colpermin® capsules.
For more information on how we can be of help, please contact us now.